These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9151308)

  • 1. Batten disease, a twenty-eight-year struggle: past, present and future.
    Rider JA; Rider DL
    Neuropediatrics; 1997 Feb; 28(1):4-5. PubMed ID: 9151308
    [No Abstract]   [Full Text] [Related]  

  • 2. [The molecular etiology of neuronal ceroid lipofuscinosis].
    Järvelä I; Hellsten E; Vesa J; Palotie L
    Duodecim; 1996; 112(13):1139-41. PubMed ID: 10596080
    [No Abstract]   [Full Text] [Related]  

  • 3. Thirty years of Batten disease research: present status and future goals.
    Rider JA; Rider DL
    Mol Genet Metab; 1999 Apr; 66(4):231-3. PubMed ID: 10191106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Batten disease--an overview of research and funding.
    Rider JA
    Am J Med Genet; 1995 Jun; 57(2):128-9. PubMed ID: 7668315
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE; de Vos N; Post JG; Meijers-Heijboer EJ; Hofman I; Loonen MC; Pinckers AJ; Bleeker-Wagemakers EM; Gardiner RM; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):333-7. PubMed ID: 7668358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16.
    Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I
    Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA diagnosis and identification of carriers of infantile and juvenile neuronal ceroid lipofuscinoses.
    Syvänen AC; Järvelä I; Paunio T; Vesa J
    Neuropediatrics; 1997 Feb; 28(1):63-6. PubMed ID: 9151326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene table: neuronal ceroid lipofuscinoses.
    Mole S
    Eur J Paediatr Neurol; 2002; 6(2):129-30. PubMed ID: 11995961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene localization will explain the basic causes of neuronal ceroid lipofuscinoses].
    Järvelä I; Palotie L; Santavuori P; Rapola J
    Duodecim; 1991; 107(8):632-5. PubMed ID: 1364917
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuronal ceroid lipofuscinoses.
    Mole S
    Eur J Paediatr Neurol; 2001; 5(5):211-2. PubMed ID: 11585111
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of apolipoprotein E genotypes in fragile X syndrome and Batten disease.
    Zhong N; Ju W; Brown WT; Ye L; Jenkins EC; Schupf N
    Am J Med Genet; 1999 May; 84(3):309-10. PubMed ID: 10331615
    [No Abstract]   [Full Text] [Related]  

  • 13. Linkage analysis in juvenile neuronal ceroid lipofuscinosis.
    Haines JL; Yan WL; Boustany RM; Jewell A; Julier C; Breakefield XO; Gusella JF
    Am J Med Genet; 1992 Feb; 42(4):542-5. PubMed ID: 1609835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the gene for juvenile onset neuronal ceroid lipofuscinosis to chromosome 16 by linkage analysis.
    Gardiner RM
    Am J Med Genet; 1992 Feb; 42(4):539-41. PubMed ID: 1351702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation 10;18 in a patient with juvenile neuronal ceroid-lipofuscinosis (Batten disease).
    Tuck-Muller CM; Dyken PR; Li S; Chen H; Labbé E; Wertelecki W
    Am J Med Genet; 1995 Jun; 57(2):168-71. PubMed ID: 7668324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From locus to cellular disturbances: positional cloning of the infantile neuronal ceroid lipofuscinosis gene.
    Hellsten E; Vesa J; Jalanko A; Peltonen L
    Neuropediatrics; 1997 Feb; 28(1):9-11. PubMed ID: 9151310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
    Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
    Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenol sulfotransferases: candidate genes for Batten disease.
    Dooley TP; Probst P; Obermoeller RD; Siciliano MJ; Doggett NA; Callen DF; Mitchison HM; Mole SE
    Am J Med Genet; 1995 Jun; 57(2):327-32. PubMed ID: 7668357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion).
    Järvelä I; Autti T; Lamminranta S; Aberg L; Raininko R; Santavuori P
    Ann Neurol; 1997 Nov; 42(5):799-802. PubMed ID: 9392580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.